Vomiting as Common Adverse Event of Exenatide: A Case of Diabetic Patient with Type 2 and Duodenal Bulb and Gastric Ulcers who Showed Severe Vomiting Increased Gradually after Exenatide Injections

doi:10.15344/2455-2356/2015/108

Graphy

Profile

New User

New to Graphy Publications? Create an account to get started today.

Create Account For:

Registered Users

Have an account? Sign in now.

Article Menu

Journal Menu

How to Cite | Author Information | Publication History

International Journal of Clinical Case Studies Volume 1 (2015), Article ID 1:IJCCS-108, 2 pages
http://dx.doi.org/10.15344/2455-2356/2015/108

Case Report

Vomiting as Common Adverse Event of Exenatide: A Case of Diabetic Patient with Type 2 and Duodenal Bulb and Gastric Ulcers who Showed Severe Vomiting Increased Gradually after Exenatide Injections

Kyuzi Kamoi^1,2* and Hideo Sasaki^3,4

¹Center Diabetes & Endocrinology Metabolism, Joetsu General Hospital, 616 Fukuda Didou, Joetsu, Niigata 943-8502, Japan
²Department of Medicine, Ojiya General Hospital, 1-3-33 Honcho, Ojiya, Niigata 947-8602, Japan
³Emeritus Professors, Yamagata University Faculty of Medicine, Yamagata, Yamagata 990-9585, Japan
⁴Diabetes Clinic, Kuriyama Central Hospital, Yotsukaido, Chiba 286-0027, Japan

Corresponding Author Details: Kyuzi Kamoi, Chief Director of Center, Diabetes & Endocrinology Metabolism, Joetsu General Hospital, 616, Fukuda Didou, Joetsu, Niigata, 943-6502, Japan; E-mail: kkam-int@echigo.ne.jp

Received: 07 July 2015; Accepted: 19 September 2015; Published: 21 September 2015

Citation: Kamoi K, Sasaki H (2015) Vomiting as Common Adverse Event of Exenatide: A Case of Diabetic Patient with Type 2 and Duodenal Bulb and Gastric Ulcers who Showed Severe Vomiting Increased Gradually after Exenatide Injections. Int J Clin Case Stud 1: 108. doi: http://dx.doi.org/10.15344/2455-2356/2015/108

Copyright: © 2015 Kamoi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

McCormack PL (2014) Exenatide twice daily: a review of its use in the management of patients with type 2 diabetes mellitus. Drugs 74: 325-351. View
Tokuda M, Katsuno T, Ochi F, Miyakoshi K, Kusunoki Y, et al. (2014) Effects of exenatide on metabolic parameters / control in obese Japanese patients with type 2 diabetes. Endocrine J 61: 365-372. View
Miyashita M, Matoba K, Sasahara T, Kizawa Y, Maruguchi M, et al. (2001) Reliability and validation of the Japanese version of the support team assessment schedule (STAS-J). Palliat Support Care 2: 379-385. View
Phillips LK, Deane AM, Jones KL, Rayner CK, Horowitz M (2015) Gastric emptying and glycaemia in health and diabetes mellitus. Nat Rev Endocrinol 11:112-128. View
Müller-Lissner SA (1988) Is a duodenogastric reflux of pathogenic significance? Z Gastroenterol 26: 637-642. View

Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version